SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-22-000017
Filing Date
2022-05-04
Accepted
2022-05-04 16:08:21
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20220331.htm   iXBRL 10-Q 1359248
2 EX-31.1 kronq1fy2022ex311.htm EX-31.1 18562
3 EX-31.2 kronq1fy2022ex312.htm EX-31.2 18527
4 EX-32.1 kronq1fy2022ex321.htm EX-32.1 11488
10 kron-20220331_g1.jpg GRAPHIC 120708
  Complete submission text file 0001741830-22-000017.txt   5885170

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20220331.xsd EX-101.SCH 36394
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20220331_cal.xml EX-101.CAL 66396
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20220331_def.xml EX-101.DEF 130994
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20220331_lab.xml EX-101.LAB 466629
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20220331_pre.xml EX-101.PRE 293243
61 EXTRACTED XBRL INSTANCE DOCUMENT kron-20220331_htm.xml XML 874445
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 22891550
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences